Fresenius Medical Care AG & Co. KGaA (FME.DE)
EUR 45.06
(-0.09%)
EUR 45.06
(-0.09%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 19.45 Billion EUR | 0.29% |
| 2022 | 19.39 Billion EUR | 10.1% |
| 2021 | 17.61 Billion EUR | -1.34% |
| 2020 | 17.85 Billion EUR | 2.19% |
| 2019 | 17.47 Billion EUR | 5.62% |
| 2018 | 16.54 Billion EUR | -6.96% |
| 2017 | 17.78 Billion EUR | 4.42% |
| 2016 | 17.03 Billion EUR | 11.24% |
| 2015 | 15.3 Billion EUR | 17.59% |
| 2014 | 13.01 Billion EUR | 23.06% |
| 2013 | 10.58 Billion EUR | 1.39% |
| 2012 | 10.43 Billion EUR | 5.7% |
| 2011 | 9.87 Billion EUR | 8.93% |
| 2010 | 9.06 Billion EUR | 15.45% |
| 2009 | 7.85 Billion EUR | 2.98% |
| 2008 | 7.62 Billion EUR | 14.35% |
| 2007 | 6.66 Billion EUR | 3.53% |
| 2006 | 6.43 Billion EUR | 12.63% |
| 2005 | 5.71 Billion EUR | 24.45% |
| 2004 | 4.59 Billion EUR | 4.68% |
| 2003 | 4.38 Billion EUR | -9.41% |
| 2002 | 4.84 Billion EUR | -11.29% |
| 2001 | 5.46 Billion EUR | 22.09% |
| 2000 | 4.47 Billion EUR | 17.21% |
| 1999 | 3.81 Billion EUR | 27.68% |
| 1998 | 2.98 Billion EUR | 0.94% |
| 1997 | 2.96 Billion EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 4.72 Billion EUR | -5.27% |
| 2024 Q3 | 4.76 Billion EUR | -0.14% |
| 2024 Q2 | 4.76 Billion EUR | 0.88% |
| 2023 Q4 | 4.98 Billion EUR | 1.05% |
| 2023 Q2 | 4.82 Billion EUR | 2.57% |
| 2023 Q3 | 4.93 Billion EUR | 2.3% |
| 2023 Q1 | 4.7 Billion EUR | -5.86% |
| 2023 FY | 19.45 Billion EUR | 0.29% |
| 2022 Q1 | 4.54 Billion EUR | -2.12% |
| 2022 FY | 19.39 Billion EUR | 10.1% |
| 2022 Q2 | 4.75 Billion EUR | 4.58% |
| 2022 Q4 | 4.99 Billion EUR | -1.95% |
| 2022 Q3 | 5.09 Billion EUR | 7.14% |
| 2021 Q1 | 4.21 Billion EUR | -4.32% |
| 2021 Q2 | 4.32 Billion EUR | 2.61% |
| 2021 Q3 | 4.44 Billion EUR | 2.81% |
| 2021 Q4 | 4.64 Billion EUR | 4.63% |
| 2021 FY | 17.61 Billion EUR | -1.34% |
| 2020 Q4 | 4.4 Billion EUR | -0.31% |
| 2020 Q1 | 4.48 Billion EUR | -2.01% |
| 2020 Q2 | 4.55 Billion EUR | 1.54% |
| 2020 Q3 | 4.41 Billion EUR | -3.14% |
| 2020 FY | 17.85 Billion EUR | 2.19% |
| 2019 Q2 | 4.34 Billion EUR | 5.14% |
| 2019 Q4 | 4.58 Billion EUR | 3.64% |
| 2019 Q3 | 4.41 Billion EUR | 1.7% |
| 2019 FY | 17.47 Billion EUR | 5.62% |
| 2019 Q1 | 4.13 Billion EUR | -3.89% |
| 2018 Q3 | 4.05 Billion EUR | -3.7% |
| 2018 Q2 | 4.21 Billion EUR | 5.98% |
| 2018 Q1 | 3.97 Billion EUR | -10.23% |
| 2018 Q4 | 4.3 Billion EUR | 5.97% |
| 2018 FY | 16.54 Billion EUR | -6.96% |
| 2017 Q3 | 4.33 Billion EUR | -3.03% |
| 2017 FY | 17.78 Billion EUR | 4.42% |
| 2017 Q4 | 4.42 Billion EUR | 2.15% |
| 2017 Q2 | 4.47 Billion EUR | -1.7% |
| 2017 Q1 | 4.54 Billion EUR | 2.05% |
| 2016 Q1 | 3.71 Billion EUR | -6.7% |
| 2016 Q4 | 4.45 Billion EUR | 8.73% |
| 2016 Q3 | 4.09 Billion EUR | 3.14% |
| 2016 Q2 | 3.97 Billion EUR | 7.1% |
| 2016 FY | 17.03 Billion EUR | 11.24% |
| 2015 Q3 | 3.76 Billion EUR | 0.45% |
| 2015 FY | 15.3 Billion EUR | 17.59% |
| 2015 Q2 | 3.74 Billion EUR | 2.37% |
| 2015 Q1 | 3.65 Billion EUR | 2.93% |
| 2015 Q4 | 3.97 Billion EUR | 5.75% |
| 2014 Q1 | 2.59 Billion EUR | -1.07% |
| 2014 Q4 | 3.55 Billion EUR | 9.61% |
| 2014 FY | 13.01 Billion EUR | 23.06% |
| 2014 Q2 | 2.81 Billion EUR | 8.48% |
| 2014 Q3 | 3.24 Billion EUR | 15.31% |
| 2013 Q2 | 2.77 Billion EUR | 2.66% |
| 2013 Q1 | 2.7 Billion EUR | 5.12% |
| 2013 FY | 10.58 Billion EUR | 1.39% |
| 2013 Q4 | 2.61 Billion EUR | -3.6% |
| 2013 Q3 | 2.71 Billion EUR | -2.16% |
| 2012 Q4 | 2.57 Billion EUR | -3.34% |
| 2012 FY | 10.43 Billion EUR | 5.7% |
| 2012 Q1 | 2.43 Billion EUR | -15.95% |
| 2012 Q2 | 2.7 Billion EUR | 11.18% |
| 2012 Q3 | 2.66 Billion EUR | -1.69% |
| 2011 FY | 9.87 Billion EUR | 8.93% |
| 2011 Q4 | 2.89 Billion EUR | 21.39% |
| 2011 Q3 | 2.38 Billion EUR | 8.19% |
| 2011 Q2 | 2.2 Billion EUR | 2.59% |
| 2011 Q1 | 2.15 Billion EUR | -15.41% |
| 2010 Q3 | 2.24 Billion EUR | -7.19% |
| 2010 Q1 | 2.14 Billion EUR | -4.26% |
| 2010 Q2 | 2.41 Billion EUR | 12.62% |
| 2010 FY | 9.06 Billion EUR | 15.45% |
| 2010 Q4 | 2.54 Billion EUR | 13.3% |
| 2009 Q2 | 1.96 Billion EUR | 2.09% |
| 2009 Q3 | 1.97 Billion EUR | 0.15% |
| 2009 Q4 | 2.24 Billion EUR | 13.67% |
| 2009 FY | 7.85 Billion EUR | 2.98% |
| 2009 Q1 | 1.92 Billion EUR | -4.81% |
| 2008 Q2 | 1.69 Billion EUR | 6.49% |
| 2008 FY | 7.62 Billion EUR | 14.35% |
| 2008 Q4 | 2.02 Billion EUR | 5.32% |
| 2008 Q3 | 1.92 Billion EUR | 13.63% |
| 2008 Q1 | 1.59 Billion EUR | -3.94% |
| 2007 Q3 | 1.7 Billion EUR | -4.28% |
| 2007 Q2 | 1.77 Billion EUR | 2.24% |
| 2007 FY | 6.66 Billion EUR | 3.53% |
| 2007 Q1 | 1.73 Billion EUR | 8.82% |
| 2007 Q4 | 1.65 Billion EUR | -2.62% |
| 2006 Q2 | 1.69 Billion EUR | 17.58% |
| 2006 Q4 | 1.59 Billion EUR | -9.33% |
| 2006 FY | 6.43 Billion EUR | 12.63% |
| 2006 Q3 | 1.76 Billion EUR | 3.89% |
| 2006 Q1 | 1.44 Billion EUR | -7.73% |
| 2005 FY | 5.71 Billion EUR | 24.45% |
| 2005 Q4 | 1.56 Billion EUR | 9.47% |
| 2005 Q3 | 1.42 Billion EUR | 3.23% |
| 2005 Q2 | 1.38 Billion EUR | 11.37% |
| 2005 Q1 | 1.24 Billion EUR | 37.2% |
| 2004 FY | 4.59 Billion EUR | 4.68% |
| 2004 Q4 | 904.71 Million EUR | -28.64% |
| 2004 Q2 | 1.27 Billion EUR | 7.46% |
| 2004 Q3 | 1.26 Billion EUR | -0.37% |
| 2004 Q1 | 1.18 Billion EUR | 32.59% |
| 2003 Q2 | 1.18 Billion EUR | -0.16% |
| 2003 Q1 | 1.18 Billion EUR | 10.98% |
| 2003 FY | 4.38 Billion EUR | -9.41% |
| 2003 Q4 | 893.2 Million EUR | -26.13% |
| 2003 Q3 | 1.2 Billion EUR | 1.83% |
| 2002 Q2 | 1.26 Billion EUR | -7.25% |
| 2002 Q3 | 1.3 Billion EUR | 3.1% |
| 2002 Q4 | 1.07 Billion EUR | -17.67% |
| 2002 FY | 4.84 Billion EUR | -11.29% |
| 2002 Q1 | 1.36 Billion EUR | -10.55% |
| 2001 FY | 5.46 Billion EUR | 22.09% |
| 2001 Q4 | 1.52 Billion EUR | 12.89% |
| 2001 Q3 | 1.34 Billion EUR | -4.62% |
| 2001 Q2 | 1.41 Billion EUR | 6.79% |
| 2001 Q1 | 1.32 Billion EUR | 41.23% |
| 2000 FY | 4.47 Billion EUR | 17.21% |
| 2000 Q4 | 937.22 Million EUR | -23.53% |
| 2000 Q3 | 1.22 Billion EUR | 12.58% |
| 2000 Q2 | 1.08 Billion EUR | 3.96% |
| 2000 Q1 | 1.04 Billion EUR | -6.72% |
| 1999 Q1 | 891.88 Million EUR | 11.96% |
| 1999 Q2 | 927.36 Million EUR | 3.98% |
| 1999 Q3 | 897.96 Million EUR | -3.17% |
| 1999 Q4 | 1.12 Billion EUR | 25.02% |
| 1999 FY | 3.81 Billion EUR | 27.68% |
| 1998 Q3 | 755.45 Million EUR | -4.93% |
| 1998 FY | 2.98 Billion EUR | 0.94% |
| 1998 Q1 | 819.87 Million EUR | 1.07% |
| 1998 Q4 | 796.62 Million EUR | 5.45% |
| 1998 Q2 | 794.62 Million EUR | -3.08% |
| 1997 Q4 | 811.18 Million EUR | 12.16% |
| 1997 Q2 | 702.26 Million EUR | 2.99% |
| 1997 FY | 2.96 Billion EUR | 0.0% |
| 1997 Q1 | 681.89 Million EUR | 0.0% |
| 1997 Q3 | 723.21 Million EUR | 2.98% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Fresenius SE & Co. KGaA | 22.29 Billion EUR | 12.76% |
| LIMES Schlosskliniken AG | 37.17 Million EUR | -52232.622% |
| M1 Kliniken AG | 316.31 Million EUR | -6050.007% |
| Maternus-Kliniken Aktiengesellschaft | 102.3 Million EUR | -18915.128% |
| MEDICLIN Aktiengesellschaft | 761.59 Million EUR | -2454.313% |
| RHÖN-KLINIKUM Aktiengesellschaft | 1.73 Billion EUR | -1021.424% |
| VITA 34 AG | 77.06 Million EUR | -25144.111% |